Graypoint LLC Royalty Pharma PLC Transaction History

Graypoint LLC

$1.52 Billion
Q3 2024

A detailed history of Graypoint LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Graypoint LLC holds 35,197 shares of RPRX stock, worth $854,583. This represents 0.07% of its overall portfolio holdings.

Number of Shares

35,197

Previous 35,195 0.01%

Holding current value

$854,583

Previous $928,000 7.22%

% of portfolio

0.07%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$25.63 - $29.27 $51 - $58	2 Added 0.01%	35,197 $995,000
Q2 2024 Jul 31, 2024	SELL	$26.26 - $29.9 $231,770 - $263,897	-8,826 Reduced 20.05%	35,195 $928,000
Q1 2024 May 02, 2024	SELL	$27.46 - $31.33 $164 - $187	-6 Reduced 0.01%	44,021 $1.34 Million
Q4 2023 Jan 29, 2024	BUY	$26.21 - $29.22 $838 - $935	32 Added 0.07%	44,027 $1.24 Million
Q3 2023 Oct 26, 2023	BUY	$26.26 - $31.38 $1,207 - $1,443	46 Added 0.1%	43,995 $1.19 Million
Q1 2023 May 02, 2023	SELL	$32.77 - $39.4 $852 - $1,024	-26 Reduced 0.06%	43,949 $1.58 Million
Q4 2022 Jan 31, 2023	SELL	$39.17 - $44.04 $1.57 Million - $1.76 Million	-40,026 Reduced 47.65%	43,975 $1.74 Million
Q2 2022 Aug 01, 2022	SELL	$37.53 - $44.22 $18.1 Million - $21.3 Million	-481,673 Reduced 85.15%	84,001 $3.53 Million
Q1 2022 Apr 19, 2022	BUY	$37.46 - $42.44 $3,371 - $3,819	90 Added 0.02%	565,674 $22 Million
Q4 2021 Jan 31, 2022	SELL	$35.17 - $42.48 $1.58 Million - $1.91 Million	-45,000 Reduced 7.37%	565,584 $22.5 Million
Q3 2021 Nov 09, 2021	BUY	$36.14 - $42.24 $15.6 Million - $18.2 Million	430,668 Added 239.37%	610,584 $22.1 Million
Q2 2021 Aug 04, 2021	BUY	$39.85 - $46.63 $7.17 Million - $8.39 Million	179,916 New	179,916 $7.38 Million

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account